Lophius Biosciences
Lophius Biosciences Signs Exclusive Korean Distribution Agreement with BL&H
The German firm has signed a deal for BL&H to distribute, market, and sell its T-Track CMV kit in South Korea once it is approved as an in vitro diagnostic.
Lophius Bio Receives $2.8M Financing, Names New CEO
NEW YORK (GenomeWeb) – Lophius Biosciences today announced it received a €2.0 million ($2.8 million) investment to fund clinical studies of its flagship product and to develop new products.
The firm also announced a new CEO and changes to its board.
Lophius Joins Germany-funded Effort to Develop MS Dx
NEW YORK (GenomeWeb News) – Lophius Biosciences today said that it has joined a research consortium that will work with the firm on developing its T-Track MS diagnostic test for initial diagnosis of multiples sclerosis and monitoring of disease progression.
Oxford Immunotec, Lophius Ink Licensing Deals for Development of T-cell-based Assays
NEW YORK (GenomeWeb News) – Oxford Immunotec and Lophius Biosciences said today that they have signed agreements providing each other access to certain intellectual property.
Cell-based Dx Firm Lophius Biosciences Raises $5.3M
NEW YORK (GenomeWeb News) – T-cell-based diagnostics development firm Lophius Biosciences today announced the closing of a financing round that brought in €4 million ($5.3 million) in funding.
Jul 27, 2011
Pairings: Jul 27, 2011
Premium
Jul 26, 2011
People in the News: Jul 26, 2011
Premium
Jul 18, 2011